Strategic Advocates LLC Catalyst Pharmaceuticals, Inc. Transaction History
Strategic Advocates LLC
- $252 Billion
- Q2 2024
A detailed history of Strategic Advocates LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Strategic Advocates LLC holds 14,142 shares of CPRX stock, worth $239,565. This represents 0.09% of its overall portfolio holdings.
Number of Shares
14,142
Previous 13,278
6.51%
Holding current value
$239,565
Previous $212 Million
3.5%
% of portfolio
0.09%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
278Shares Held
95.8MCall Options Held
40.6KPut Options Held
67.2K-
Black Rock Inc. New York, NY17.7MShares$300 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$155 Million3.01% of portfolio
-
State Street Corp Boston, MA8.15MShares$138 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.98MShares$135 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.74MShares$46.4 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $1.74B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...